These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15920661

  • 1. Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors.
    Kim SH, Kim H, Kim TS.
    Acta Neuropathol; 2005 Jul; 110(1):27-38. PubMed ID: 15920661
    [Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 01; 33(10):752-8. PubMed ID: 22335907
    [Abstract] [Full Text] [Related]

  • 4. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.
    Clin Neuropathol; 2006 Oct 01; 25(1):18-24. PubMed ID: 16465770
    [Abstract] [Full Text] [Related]

  • 5. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2002 Mar 01; 103(3):267-75. PubMed ID: 11907807
    [Abstract] [Full Text] [Related]

  • 6. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
    McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K.
    Cancer; 2005 Oct 01; 104(7):1468-77. PubMed ID: 16088966
    [Abstract] [Full Text] [Related]

  • 7. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):126-34. PubMed ID: 20362227
    [Abstract] [Full Text] [Related]

  • 8. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji M, Fortin D, Tsanaclis AM, Drouin R.
    Cancer Genet Cytogenet; 2009 Oct 15; 194(1):12-22. PubMed ID: 19737649
    [Abstract] [Full Text] [Related]

  • 9. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR.
    Chin Med J (Engl); 2010 Dec 15; 123(24):3566-73. PubMed ID: 22166632
    [Abstract] [Full Text] [Related]

  • 10. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 Dec 15; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 11. Survival analysis of presumptive prognostic markers among oligodendrogliomas.
    McLendon RE, Herndon JE, West B, Reardon D, Wiltshire R, Rasheed BK, Quinn J, Friedman HS, Friedman AH, Bigner DD.
    Cancer; 2005 Oct 15; 104(8):1693-9. PubMed ID: 16116609
    [Abstract] [Full Text] [Related]

  • 12. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.
    Huang L, Jiang T, Yuan F, Li GL, Cui Y, Liu EZ, Wang ZC.
    Neuropathol Appl Neurobiol; 2009 Aug 15; 35(4):367-379. PubMed ID: 19019173
    [Abstract] [Full Text] [Related]

  • 13. Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.
    Durand K, Guillaudeau A, Pommepuy I, Mesturoux L, Chaunavel A, Gadeaud E, Porcheron M, Moreau JJ, Labrousse F.
    J Clin Pathol; 2011 Sep 15; 64(9):793-801. PubMed ID: 21653654
    [Abstract] [Full Text] [Related]

  • 14. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.
    Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, Beiske K.
    Am J Surg Pathol; 2006 Jul 15; 30(7):828-37. PubMed ID: 16819324
    [Abstract] [Full Text] [Related]

  • 15. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
    Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K.
    Cancer; 2003 May 01; 97(9):2254-61. PubMed ID: 12712480
    [Abstract] [Full Text] [Related]

  • 16. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
    Barresi V, Buttarelli FR, Vitarelli EE, Arcella A, Antonelli M, Giangaspero F.
    Hum Pathol; 2009 Dec 01; 40(12):1738-46. PubMed ID: 19716156
    [Abstract] [Full Text] [Related]

  • 17. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A, German Glioma Network.
    Clin Cancer Res; 2007 Dec 01; 13(23):6933-7. PubMed ID: 18056167
    [Abstract] [Full Text] [Related]

  • 18. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM.
    Cancer; 2003 Mar 01; 97(5):1276-84. PubMed ID: 12599236
    [Abstract] [Full Text] [Related]

  • 19. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.
    Cancer; 2006 Oct 15; 107(8):1891-7. PubMed ID: 16986124
    [Abstract] [Full Text] [Related]

  • 20. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW, Broholm H, Laursen H.
    Ugeskr Laeger; 2006 Oct 30; 168(44):3813-6. PubMed ID: 17118240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.